VCAM1 and Alzheimer disease: Similarly, microvascular injury biomarkers such as vascular cell adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) are released during global and regional cerebral hypoperfusion, a phenomenon associated with neurodegenerative diseases like AD [78].